These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 25995293)

  • 21. Effects of co-existing α-thalassaemia in sickle cell disease on hydroxycarbamide therapy and circulating nucleic acids.
    Vasavda N; Woodley C; Allman M; Drašar E; Awogbade M; Howard J; Thein SL
    Br J Haematol; 2012 Apr; 157(2):249-52. PubMed ID: 22082280
    [No Abstract]   [Full Text] [Related]  

  • 22. Newborn screening for haemoglobinopathies: the Brussels experience.
    Gulbis B; Tshilolo L; Cotton F; Lin C; Vertongen F
    J Med Screen; 1999; 6(1):11-5. PubMed ID: 10321364
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sickle cell anemia in northern Israel: screening and prevention.
    Koren A; Zalman L; Palmor H; Zamir RB; Levin C; Openheim A; Daniel-Spiegel E; Shalev S; Filon D
    Isr Med Assoc J; 2009 Apr; 11(4):229-34. PubMed ID: 19603597
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chronic Administration of Hydroxyurea (HU) Benefits Caucasian Patients with Sickle-Beta Thalassemia.
    Di Maggio R; Hsieh MM; Zhao X; Calvaruso G; Rigano P; Renda D; Tisdale JF; Maggio A
    Int J Mol Sci; 2018 Feb; 19(3):. PubMed ID: 29495591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of zinc therapy in prevention of crisis in sickle cell anemia: a double blind, randomized controlled clinical trial.
    Gupta VL; Chaubey BS
    J Assoc Physicians India; 1995 Jul; 43(7):467-9. PubMed ID: 8713219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Approximately 40 000 children with sickle cell anemia require screening with TCD and treating with hydroxyurea for stroke prevention in three states in northern Nigeria.
    Galadanci AA; Galadanci NA; Jibir BW; Abdullahi SU; Idris N; Gambo S; Ali Abubakar SA; Kabo NA; Bello-Manga H; Haliru L; Bashir I; Aliyu MH; Galadanci JA; DeBaun MR
    Am J Hematol; 2019 Nov; 94(11):E305-E307. PubMed ID: 31423630
    [No Abstract]   [Full Text] [Related]  

  • 27. [Monitoring pregnant patients from risk countries with sickle cell disease and thalassemia. Clinical aspects, screening and prenatal diagnosis].
    Dickerhoff R; Kulozik AE; Kohne E
    Geburtshilfe Frauenheilkd; 1993 Apr; 53(4):215-21. PubMed ID: 8491363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening for sickle cell disease and thalassaemia: a systematic review with supplementary research.
    Davies SC; Cronin E; Gill M; Greengross P; Hickman M; Normand C
    Health Technol Assess; 2000; 4(3):i-v, 1-99. PubMed ID: 10840658
    [No Abstract]   [Full Text] [Related]  

  • 29. Government announces improved screening for haemoglobinopathies.
    Pract Midwife; 2000 Nov; 3(10):7. PubMed ID: 12026499
    [No Abstract]   [Full Text] [Related]  

  • 30. The Prevalence of Sickle Cell Disease and Its Implication for Newborn Screening in Germany (Hamburg Metropolitan Area).
    Grosse R; Lukacs Z; Cobos PN; Oyen F; Ehmen C; Muntau B; Timmann C; Noack B
    Pediatr Blood Cancer; 2016 Jan; 63(1):168-70. PubMed ID: 26275168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thirty-year experience in preventing haemoglobinopathies in Greece: achievements and potentials for optimisation.
    Ladis V; Karagiorga-Lagana M; Tsatra I; Chouliaras G
    Eur J Haematol; 2013 Apr; 90(4):313-22. PubMed ID: 23331260
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Screening for sickle cell disease and thalassaemia saving lives.
    Kmietowicz Z
    BMJ; 2004 Jul; 329(7457):69. PubMed ID: 15242893
    [No Abstract]   [Full Text] [Related]  

  • 33. Global epidemiology of haemoglobin disorders and derived service indicators.
    Modell B; Darlison M
    Bull World Health Organ; 2008 Jun; 86(6):480-7. PubMed ID: 18568278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sickle cell disease from Africa to Belgium, from neonatal screening to clinical management.
    Lê PQ; Ferster A; Cotton F; Vertongen F; Vermylen C; Vanderfaeillie A; Dedeken L; Heijmans C; Ketelslegers O; Dresse MF; Gulbis B
    Med Trop (Mars); 2010 Dec; 70(5-6):467-70. PubMed ID: 21516988
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Exposure to hydroxyurea during pregnancy in sickle-beta thalassemia: a report of 2 cases.
    Italia KY; Jijina FF; Chandrakala S; Nadkarni AH; Sawant P; Ghosh K; Colah RB
    J Clin Pharmacol; 2010 Feb; 50(2):231-4. PubMed ID: 19797538
    [No Abstract]   [Full Text] [Related]  

  • 36. Sickle cell disease: the case for coordinated information.
    Streetly A; Dick M; Layton M
    BMJ; 1993 Jun; 306(6891):1491-2. PubMed ID: 8518672
    [No Abstract]   [Full Text] [Related]  

  • 37. [Epidemiology of genetic hemoglobin diseases in metropolitan France].
    Lena-Russo D; North ML; Girot R
    Rev Prat; 1992 Oct; 42(15):1867-72. PubMed ID: 1485078
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Sickle cell disease in the neonatal period].
    de Montalembert M
    J Gynecol Obstet Biol Reprod (Paris); 2004 Feb; 33(1 Suppl):S12-4. PubMed ID: 14968012
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute splenic sequestration in female children with sickle cell disease in the North of Jordan.
    Al-Rimawi HS; Abdul-Qader M; Jallad MF; Amarin ZO
    J Trop Pediatr; 2006 Dec; 52(6):416-20. PubMed ID: 16951418
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Thalassemia and sickle-cell disease in Norway].
    Graesdal JS; Gundersen K; Holm B; Waage A
    Tidsskr Nor Laegeforen; 2001 Feb; 121(6):678-80. PubMed ID: 11293347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.